Martine A. Rothblatt serves as Executive at UNITED THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Martine A. Rothblatt has executed 4994 insider transactions totaling $1.1B, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 6, 2024 involved selling 957 shares valued at $229.7K.
Martine A. Rothblatt currently holds 130 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martine A. Rothblatt has been a net seller of UTHR stock. They have purchased $15.1M and sold $1.0B worth of shares.
Martine A. Rothblatt's most recent insider trade was on Mar 6, 2024, when they sold 957 shares at $240.00 per share.
Get notified when new Form 4 filings are submitted
| $129.49 |
| Planned |
| Mar 6, 2024 | UTHR | $48.1K | Sale | 209 | $230.28 | Planned |
| Mar 6, 2024 | UTHR | $258.6K | Sale | 1,116 | $231.73 | Planned |
| Mar 6, 2024 | UTHR | $130.4K | Sale | 559 | $233.27 | Planned |
| Mar 6, 2024 | UTHR | $571.6K | Sale | 2,437 | $234.57 | Planned |
| Mar 6, 2024 | UTHR | $302.1K | Sale | 1,284 | $235.25 | Planned |
| Mar 6, 2024 | UTHR | $1.2M | Sale | 5,219 | $236.77 | Planned |
| Mar 6, 2024 | UTHR | $320.3K | Sale | 1,348 | $237.61 | Planned |
| Mar 6, 2024 | UTHR | $447.3K | Sale | 1,871 | $239.05 | Planned |
| Mar 5, 2024 | UTHR | $815.8K | Option Exercise | 6,300 | $129.49 | Planned |
| Mar 5, 2024 | UTHR | $790.4K | Sale | 3,431 | $230.36 | Planned |
| Mar 5, 2024 | UTHR | $559.4K | Sale | 2,416 | $231.53 | Planned |
| Mar 5, 2024 | UTHR | $105.1K | Sale | 453 | $232.08 | Planned |
| Mar 4, 2024 | UTHR | $118.5K | Option Exercise | 915 | $129.49 | Planned |
| Mar 4, 2024 | UTHR | $114.3K | Sale | 491 | $232.79 | Planned |
| Mar 4, 2024 | UTHR | $96.2K | Sale | 417 | $230.58 | Planned |
| Mar 4, 2024 | UTHR | $1.6K | Sale | 7 | $231.39 | Planned |
| Mar 1, 2024 | UTHR | $231.3K | Sale | 987 | $234.32 | Planned |
| Mar 1, 2024 | UTHR | $147.2K | Sale | 626 | $235.13 | Planned |
| Mar 1, 2024 | UTHR | $330.3K | Sale | 1,398 | $236.24 | Planned |
| Mar 1, 2024 | UTHR | $51.8K | Sale | 218 | $237.46 | Planned |
| Mar 1, 2024 | UTHR | $942.2K | Sale | 4,046 | $232.87 | Planned |
| Mar 1, 2024 | UTHR | $1.3M | Sale | 5,773 | $232.04 | Planned |
| Mar 1, 2024 | UTHR | $451.1K | Sale | 1,952 | $231.11 | Planned |
| Mar 1, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| May 2, 2023 | UTHR | $904.6K | Option Exercise | 8,000 | $113.08 | Discretionary |
| May 2, 2023 | UTHR | $1.0M | Sale | 4,416 | $227.79 | Discretionary |
| May 2, 2023 | UTHR | $424.8K | Sale | 1,858 | $228.61 | Discretionary |
| May 2, 2023 | UTHR | $151.7K | Sale | 661 | $229.52 | Discretionary |